Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
15.1M
-
Shares change
-
-249K
-
Total reported value, excl. options
-
$251M
-
Value change
-
-$6.06M
-
Put/Call ratio
-
1.06
-
Number of buys
-
28
-
Number of sells
-
-24
-
Price
-
$16.60
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q3 2021
78 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q3 2021.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.1M shares
of 144M outstanding shares and own 10.52% of the company stock.
Largest 10 shareholders include FMR LLC (2.41M shares), ORBIMED ADVISORS LLC (2.26M shares), BlackRock Inc. (1.29M shares), Knoll Capital Management, LLC (1.03M shares), Point72 Asset Management, L.P. (1.02M shares), VANGUARD GROUP INC (850K shares), FRANKLIN RESOURCES INC (834K shares), Rock Springs Capital Management LP (702K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (640K shares), and ALKEON CAPITAL MANAGEMENT LLC (639K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.